Factor V Leiden
Factor V Leiden is a genetic mutation that increases the risk of developing blood clots, also known as thrombophilia. Normally, factor V is a protein that helps blood clot when there is an injury. However, the mutation causes factor V to be resistant to the normal inhibition by protein C, and this results in excess formation of blood clots. Factor V Leiden is inherited in an autosomal dominant pattern, meaning that only one copy of the gene is needed for a person to develop this condition. It is most common among people of European descent, with a prevalence of around 5%. Individuals with factor V Leiden have an increased risk of developing deep vein thrombosis (DVT) and pulmonary embolism (PE), which are potentially life-threatening conditions. Some studies have also shown an increased risk of other thrombotic events such as stroke, heart attack, and pregnancy loss. Diagnosis of factor V Leiden is typically made through a blood test. Treatment may involve blood-thinning medication to help prevent the formation of blood clots. Lifestyle changes such as regular exercise, maintaining a healthy weight, and avoiding smoking can also help reduce the risk of blood clots. Overall, it is important for individuals with a family history of factor V Leiden or those who have experienced blood clots to speak with their healthcare provider and undergo appropriate testing and treatment to prevent potentially serious complications.
← Hematology Research and Oncology Research